SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma
SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma
复制标题
SP1/AKT/FOXO3 信号转导参与 miR-362-3p 介导的肾细胞癌细胞周期途径和 EMT 进展的抑制
DOI:
10.3389/fcell.2020.00297
复制
发表时间:
2020-05
影响因子:
5.5
通讯作者:
Xu Xin
中科院分区:
文献类型:
--
作者:
Zhu Hejia;Wang Song;Shen Haixiang;Zheng Xiangyi;Xu Xin
Emerging evidence has indicated that dysregulation of miR-362-3p is involved in the initiation and progression of several types of human cancers. However, the molecular mechanism of miR-362-3p in renal cell carcinoma (RCC) is still not completely clear. In this study, we found that miR-362-3p was frequently down-regulated in human RCC tissues. Overexpression of miR-362-3p in RCC cells significantly suppressed the proliferation, cell cycle and motility in vitro and in vivo via regulating AKT/FOXO3 signaling. We further confirmed that SP1 was a direct target of miR-362-3p. Knockdown of SP1 expression by a small interfering RNA (siRNA) phenocopied the effect of miR-362-3p overexpression in RCC cells. In conclusion, the current results provide evidence for the role of miR-362-3p in the pathogenesis of RCC and thus miR-362-3p may serve as an attractive candidate for RCC therapy.
登录
查看更多内容
影响因子:
37.3
作者:
Wang Y;Wang L;Chen C;Chu X
通讯作者:
Chu X
影响因子:
37.3
作者:
Liu Y;Ao X;Ding W;Ponnusamy M;Wu W;Hao X;Yu W;Wang Y;Li P;Wang J
通讯作者:
Wang J
影响因子:
9.7
作者:
Chen, Hong;Lin, Yi-Wei;Xie, Li-Ping
通讯作者:
Xie, Li-Ping
DOI:
10.14343/jcscr.2016.4e1003
发表时间:
2016
期刊:
--
影响因子:
--
作者:
M. Štimpfel;I. Virant-Klun
通讯作者:
M. Štimpfel;I. Virant-Klun
影响因子:
5.3
作者:
Guanghua Liu;Zixing Ye;Xin Zhao;Z. Ji
通讯作者:
Guanghua Liu;Zixing Ye;Xin Zhao;Z. Ji